Bronchial provocation testing with dry powder mannitol in children with cystic fibrosis

Caro Minasian, Colin Wallis, Chris Metcalfe, Andrew Bush

Research output: Contribution to journalArticle (Academic Journal)peer-review

15 Citations (Scopus)

Abstract

There has been recent interest in dry powder inhaled mannitol as a therapeutic agent in patients with cystic fibrosis (CF). It is has been shown to increase mucociliary clearance (MCC) by rehydrating the airway. To date there have been no studies exclusively in children with CF examining the effect of dry powder mannitol on the airways. The aim of this study was to determine acute tolerability of inhaled mannitol in children with CF.
Original languageEnglish
Pages (from-to)1078-84
Number of pages7
JournalPediatric Pulmonology
Volume43
Issue number11
DOIs
Publication statusPublished - 2008

Fingerprint Dive into the research topics of 'Bronchial provocation testing with dry powder mannitol in children with cystic fibrosis'. Together they form a unique fingerprint.

Cite this